Related Experiment Video
Updated: Jul 16, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Molecular targets in gynaecological cancers
1Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. anycheun@hkucc.hku.hk
Advanced molecular techniques are revolutionizing gynecological cancer care, improving early detection and personalized treatments. Pathologists play a key role, but molecular target interpretation requires clinical context and quality assurance.
Area of Science:
- Oncology
- Molecular Biology
- Gynecologic Oncology
Background:
- High-throughput expression profiling and advanced molecular biology techniques are transforming cancer management.
- These novel approaches are increasingly relevant to gynecological cancers, offering new insights into carcinogenesis.
Purpose of the Study:
- To explore the application of molecular targets in understanding and managing gynecological cancers.
- To highlight the potential for personalized medicine and improved diagnostics in this field.
Main Methods:
- Utilizing high-throughput expression profiling and advanced molecular laboratory techniques.
- Investigating molecular targets within signaling pathways involved in carcinogenesis.
- Examining applications such as human papillomavirus detection, methylation, telomerase, and clonality studies.
Main Results:
- Molecular techniques offer improved understanding of carcinogenesis and facilitate early detection of gynecological cancers.
- Personalized prediction of patient therapy response and targeted therapy design are becoming feasible.
- Established applications include human papillomavirus detection in cervical cancer management; methylation, telomerase, and clonality studies aid in complex diagnoses.
Conclusions:
- The post-genomic era significantly impacts routine pathology, with pathologists crucial for analyzing tissue microarrays.
- Awareness of molecular target limitations and integration with clinical/histopathological data are essential for accurate interpretation.
- Robust quality assurance and ethical considerations are paramount for these molecular techniques in gynecological oncology.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
